Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
NPM1 Mutation Assay
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Invivoscribe Techno
Type:
Laboratory Developed Test
Related tests:
‹
LeukoStrat® CDx FLT3 Mutation Assay (6)
FLT3 ITD MRD Assay
LymphoTrack® Dx IGH Assay
LymphoTrack® Dx IGK Assay
LymphoTrack® TRB Assay Panel
LymphoTrack® TRG Assay
LeukoStrat® CDx FLT3 Mutation Assay (6)
FLT3 ITD MRD Assay
LymphoTrack® Dx IGH Assay
LymphoTrack® Dx IGK Assay
LymphoTrack® TRB Assay Panel
LymphoTrack® TRG Assay
›
Details
Evidence
News
Search handles
Search handles
Filter by
Latest
over1year
In 454 patients transplanted 2013-2018 we clearly show clinical utility for residual FLT3-ITD and/or NPM1 mutation testing pre-alloHCT. This is definitive and the largest dataset of AML NGS-MRD put together & has advantage of being focused on specific subset and context of use. ()
over 1 year ago
Clinical • Next-generation sequencing
|
FLT3 (Fms-related tyrosine kinase 3) • NPM1 (Nucleophosmin 1)
|
FLT3-ITD mutation • NPM1 mutation
|
NPM1 Mutation Assay
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login